Driving Forces Behind the In-Vitro Transcription Templates Market in 2025: Spotlight on Gene Therapy Advancements Drive Growth In In-Vitro Transcription Templates Market Driver
The in-vitro transcription templates market size is expected to see exponential growth in the next few years. It will grow to $2.9 billion in 2029 at a compound annual growth rate (CAGR) of 23.4%. The growth in the forecast period can be attributed to Increase in advancement in biotechnology, rise in focus in R&D activities, rise in usage of in-vitro transcription templates, demand for early diagnosis of diseases and increasing need for mRNA-based vaccines. Major trends in the forecast period include developments in RNA synthesis technologies, technological advancements, advancement in biotechnology, advancements in enzymatic synthesis techniques, and integration of automation and digitalization.
Get Your Free Sample of The Global In-Vitro Transcription Templates Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15838&type=smp
What are the key drivers behind the rapid expansion of the in-vitro transcription templates market?
The increasing focus on gene therapy is expected to propel the growth of the in-vitro transcription templates market. Gene therapy involves modifying genes within cells to treat or prevent diseases by correcting defective genes. Advances in technologies such as CRISPR, significant investment, and recent treatment successes have increased focus on this approach. In-vitro transcription templates help in gene therapy by providing the RNA molecules necessary for mRNA-based therapies, siRNA-based therapies, and gene editing technologies, enabling the treatment of genetic disorders and diseases. For instance, in March 2024, the Food and Drug Administration (FDA), a US-based federal agency of the Department of Health and Human Services, estimated that 36 gene therapies were approved by the FDA, with an additional 500 in the pipeline and the expectation that 10-20 will be approved annually by 2025. Therefore, the increasing focus on gene therapy is driving the growth of the in-vitro transcription templates market.
What is the segmentation for the in-vitro transcription templates market?
The in-vitro transcription templates market covered in this report is segmented –
1) By Treatment: Vaccine, Therapeutic
2) By Research Stage: Exploratory, Clinical
3) By Disease: Cancer, Infectious Disease, Lifestyle Disease, Genetic Disease, Other Diseases
4) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs), Academics And Research, Other End Users
Subsegments:
1) By Vaccine: MRNA Vaccines, DNA Vaccines
2) By Therapeutic: Gene Therapy, RNA-Based Therapeutics
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/in-vitro-transcription-templates-global-market-report
Who are the most influential companies in the in-vitro transcription templates market?
Major companies operating in the in-vitro transcription templates market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Eurofins Genomics LLC, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Integrated DNA Technologies Inc., Promega Corporation, Genescript Biotech Corporation, Takara Bio Inc., New England Biolabs, OriGene Technologies Inc., Cayman Chemical, Synthego Corporation, Synbio Technologies, Creative Diagnostics, VectorBuilder Inc., Bio-Synthesis Inc., TriLink BioTechnologies, Norgen Biotek Corporation, Genaxxon BioScience GmbH, Enzo Life Sciences Inc., GeneCopoeia
What are the most influential trends expected to drive the in-vitro transcription templates market forward?
Major companies operating in the in-vitro transcription templates market are developing self-amplifying RNA synthesis services to enhance the efficiency and effectiveness of RNA-based therapies, reduce production costs, and improve patient outcomes in various therapeutic applications. Self-amplifying RNA synthesis service is a technology that enables the production of RNA capable of replicating itself within host cells, leading to enhanced protein expression from minimal RNA input, thereby improving the efficiency and effectiveness of RNA-based therapies. For instance, in May 2024, GenScript Biotech Corporation, a US-based biotechnology company, launched a self-amplifying RNA (saRNA) synthesis service, expanding its in vitro transcription RNA synthesis portfolio. This new service enhances the potency and efficacy of vaccines, immunotherapies, and gene therapies by enabling robust protein expression from a small amount of RNA. The saRNA platform promises to reduce dosages, lower production costs, and improve patient outcomes. Supported by extensive research and development, GenScript's saRNA exhibits high purity and enhanced protein expression, ensuring reliable performance.
What are the major regional insights for the in-vitro transcription templates market, and which region holds the top position?
North America was the largest region in the in-vitro transcription templates market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro transcription templates market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The In-Vitro Transcription Templates Market Report 2025 Offer?
The in-vitro transcription templates market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
In-vitro transcription templates are DNA sequences designed to serve as the blueprint for RNA synthesis in a controlled laboratory setting. These templates contain specific promoter regions recognized by RNA polymerase, facilitating the production of RNA molecules for various applications, including research, diagnostic development, and therapeutic production. They provide a precise and reliable source for RNA generation, along with molecular biology and genetic research.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15838
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Comments
Post a Comment